{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:05:48Z","timestamp":1790661948692,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T00:00:00Z","timestamp":1265328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold> The present study reports on the preparation and testing of a sustained delivery system for the immunomodulatory peptide P10 aimed at reducing the <jats:italic>in vivo<\/jats:italic> degradation of the peptide and the amount required to elicit a protective immune response against paracoccidioidomycosis.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold> BALB\/c mice were infected with the yeast <jats:italic>Paracoccidioides brasiliensis<\/jats:italic> to mimic the chronic form of paracoccidioidomycosis. The animals were treated daily with sulfamethoxazole\/trimethoprim alone or combined with peptide P10, either emulsified in Freund's adjuvant or entrapped in poly(lactic acid\u2010glycolic acid) (PLGA) nanoparticles at different concentrations (1\u2003\u00b5g, 5\u2003\u00b5g, 10\u2003\u00b5g, 20\u2003\u00b5g or 40\u2003\u00b5g\u00b750\u2003\u00b5L<jats:sup>\u22121<\/jats:sup>). Therapeutic efficacy was assessed as fungal burden in tissues and the immune response by quantitative determination of cytokines.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold> Animals given combined chemotherapy and P10 nanotherapy presented a marked reduction of fungal load in the lungs, compared with the non\u2010treated animals. After 30 days of treatment, P10 entrapped within PLGA (1\u2003\u00b5g\u00b750\u2003\u00b5L<jats:sup>\u22121<\/jats:sup>) was more effective than \u2018free\u2019 P10 emulsified in Freund's adjuvant (20\u2003\u00b5g\u00b750\u2003\u00b5L<jats:sup>\u22121<\/jats:sup>), as an adjuvant to chemotherapy. After treatment for 90 days, the higher doses of P10 entrapped within PLGA (5 or 10\u2003\u00b5g\u00b750\u2003\u00b5L<jats:sup>\u22121<\/jats:sup>) were most effective. Treatment with P10 emulsified in Freund's adjuvant (20\u2003\u00b5g\u00b750\u2003\u00b5L<jats:sup>\u22121<\/jats:sup>) or P10 entrapped within PLGA (1\u2003\u00b5g\u00b750\u2003\u00b5L<jats:sup>\u22121<\/jats:sup>) were accompanied by high levels of interferon\u2010gamma in lung.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold> Combination of sulfamethoxazole\/trimethoprim with the P10 peptide entrapped within PLGA demonstrated increased therapeutic efficacy against paracoccidioidomycosis. P10 incorporation into PLGA nanoparticles dramatically reduced the peptide amount necessary to elicit a protective effect.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00617.x","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T14:03:51Z","timestamp":1265378631000},"page":"1126-1132","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Poly(lactic acid\u2010glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis"],"prefix":"10.1111","volume":"159","author":[{"given":"Andr\u00e9 C","family":"Amaral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre F","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n E","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam\u00e9lia L","family":"Bocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreza R","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo C","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz R","family":"Travassos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos P","family":"Taborda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sueli S","family":"Felipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"issue":"2","key":"e_1_2_8_2_1","first-page":"S1","article-title":"Guide to Receptors and Channels (GRAC), 3rd edition (2008 revision)","volume":"153","author":"Alexander SPH","year":"2008","journal-title":"Br J Pharmacol"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn539"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.6.2.89"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-007-9048-1"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2006.00198.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1537"},{"key":"e_1_2_8_8_1","first-page":"41","article-title":"Current knowledge on pathogens and immunodiagnosis of paracoccidioidomycosis","volume":"17","author":"De Camargo ZP","year":"2000","journal-title":"Rev Iberoam Micol"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1998.tb01145.x"},{"key":"e_1_2_8_10_1","first-page":"746","article-title":"Poly (DL\u2010lactide\u2010co\u2010glycolide) based delivery systems for vaccines and drugs","volume":"38","author":"Dhiman N","year":"2000","journal-title":"Indian J Exp Biol"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioeng.2007.08.013"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2007.11.012"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8456301"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2004.12.026"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2004.09.003"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(00)01437-2"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.progpolymsci.2005.09.004"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03218355"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.3.321"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00220-06"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.01.016"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(01)01521-0"},{"key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/iai.53.1.199-206.1986","article-title":"Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen","volume":"53","author":"Puccia R","year":"1986","journal-title":"Infect Immun"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.1.190"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/02681219280000331"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/IAI.66.2.786-793.1998","article-title":"Mapping of the T\u2010Cell epitope in the major 3\u2010Kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th\u20101 response protective against fungal infection in BALB\/c mice","volume":"66","author":"Taborda CP","year":"1998","journal-title":"Infect Immun"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0300-9475.2004.01359.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-10380-7_15"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.6.2.251"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-007-9056-1"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2005.11.006"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00617.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00617.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:14:28Z","timestamp":1694650468000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00617.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00617.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00617.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"2010-03-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}